Postoperative Stereotactic Body Radiotherapy for Spinal Metastases and the Impact of Epidural Disease Grade

35Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.
Get full text

Abstract

BACKGROUND: Postoperative stereotactic body radiotherapy (pSBRT) is an emerging indication for spinal metastases (SM). OBJECTIVE: To report our experience with pSBRT for SM. METHODS: A retrospective chart review was performed for prospectively collected data of patients treated between September 2008 to December 2015 with pSBRT and followed with serial spinal MRIs every 2 to 3 mo until death or last follow-up. Univariate and multivariable analyses were performed to identify predictive factors. RESULTS: A total of 83 spinal segments in 47 patients treated with a median dose of 24 Gy in 2 fractions were included, with mostly lung and breast primaries. A total of 59.3% had preoperative high-grade epidural disease (ED) and 39.7% were unstable. The 12-mo cumulative incidence of local failure was 17% for all segments, and 33.3%, 21.8%, and 0% in segments with postoperative high-grade, low-grade, and no ED, respectively. Downgrading preoperative ED was predictive of better local control (P =. 03). The grade of postoperative ED was also predictive for local control (P

Cite

CITATION STYLE

APA

Alghamdi, M., Sahgal, A., Soliman, H., Myrehaug, S., Yang, V. X. D., Das, S., … Tseng, C. L. (2019). Postoperative Stereotactic Body Radiotherapy for Spinal Metastases and the Impact of Epidural Disease Grade. Clinical Neurosurgery, 85(6), E1111–E1118. https://doi.org/10.1093/neuros/nyz349

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free